SNCA and Parkinson disease: Interestingly, soluble oligomers of α-synuclein are also enriched in PD patients, and they likely represent an early aggregated form of the protein that over time transitions to much larger, insoluble aggregates and amyloid fibrils (Sharon et al., 2003).